Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
International Journal of Cancer|March 15, 1985
Malignant melanoma: cross-reacting (common) tumor rejection antigensV J Hearing, W D Vieira, L W LawCancer Research|November 15, 1987
A unique tumor rejection antigen from the S91 murine malignant melanomaL W Law, W D Vieira, K Kameyama, et al.Human Gene Therapy|June 2, 2001
An episomally maintained MDR1 gene for gene therapyC G Lee, W D Vieira, I Pastan, et al.International Journal of Cancer|January 2, 1991
Suppression of established pulmonary metastases by murine melanoma-specific monoclonal antibodiesV J Hearing, S P Leong, W D Vieira, et al.Melanoma Research|June 1, 1991
Serological characterization of a shared melanoma-associated antigen of mouse melanomas: relationship to the B700 glycoproteinA B DeLeo, V J Hearing, W D Vieira, et al.Biochimica Et Biophysica Acta|April 12, 1994
Further studies of the therapeutic effects of murine melanoma-specific monoclonal antibodiesL W Law, W D Vieira, V J Hearing, et al.Gene Therapy|March 1, 2000
Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in miceT Licht, S K Goldenberg, W D Vieira, et al.International Journal of Cancer|June 15, 1990
Differentiation and the tumorigenic and metastatic phenotype of murine melanoma cellsK Kameyama, W D Vieira, K Tsukamoto, et al.Biochimica Et Biophysica Acta|February 14, 1992
Production of monoclonal antibodies against the B700 murine melanoma antigen and their antimetastatic propertiesD M Gersten, D Moody, W D Vieira, et al.Journal of Cell Science|June 1, 1995
Modulation of melanogenic protein expression during the switch from eu- to pheomelanogenesisT Kobayashi, W D Vieira, B Potterf, et al.Pageof 3